Excellent
Fully Aligned
Patient Risk:
Low
Summary
The AI-generated content matches the FDA boxed warning (Section 5) and related non-boxed warning language for abuse/misuse, addiction/substance use disorder, overdose/death, and increased risk with higher doses and unapproved methods such as snorting or injection.
Category Scores
Accurate Statements
Adderall® has a high potential for abuse and misuse leading to the development of a substance use disorder, including addiction.
Section 5 — WARNINGS (Boxed Warning): “Adderall® has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction.”
Misuse and abuse of CNS stimulants including Adderall® can result in overdose and death.
Section 5 — WARNINGS (Boxed Warning): “Misuse and abuse of CNS stimulants, including Adderall®, can result in overdose and death.”
The risk is increased with higher doses.
Section 5 — WARNINGS (Boxed Warning): “this risk is increased with higher doses …”
The risk is increased with unapproved methods of administration such as snorting or injection.
Section 5 — WARNINGS (Boxed Warning): “such as snorting or injection.”
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated AI claims are directly supported by the boxed warning text and do not introduce incorrect safety statements.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement